T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation

International Journal of Laboratory Hematology

Volumn 30, Issue 6, 2008, Pages 499-507

  Kircher, B ^a   Niederwieser, D ^a,b   Gachter A ^a   Lindner, B ^c   Mitterschiffthaler, A ^d   Urban, C ^e   Greinix, H ^f   Peters, C ^g   Latzer K ^a   Gastl, G ^a   Nachbaur, D ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Department of Internal Medicine II   (Germany)

^c Austrian Stem Cell Transplantation Registry   (Austria)

^d Austrian Bone Marrow Donor Registry   (Austria)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Cytotoxic T lymphocyte precursor frequency; Graft vs. host disease; Helper T lymphocyte precursor frequency; Limiting dilution analysis; Unrelated stem cell transplantation

Indexed keywords

CYCLOSPORIN A; METHOTREXATE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PRECURSOR CELLS, T-LYMPHOID; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 55149123989     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00990.x     Document Type: Article

References (27)

1. Barnardo M.C.N.M., Davey N.J., Bunce M., Brookes P.A., Lechler R.I., Welsh K.I. Batchelor J.R. (1996) A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation. Transplantation 61, 1420 1423.
2. Chalandon Y., Tiercy J.-M., Schanz U., Gungor T., Seger R., Halter J., Helg C., Chapuis B., Gratwohl A., Tichelli A., Nicoloso de Faveri G., Roosnek E. Passweg J.R. (2006) Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplantation 37, 909 916.
3. Fussel S.T., Donnellan M., Cooley M.A. Farrell C. (1994) Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation 57, 673 676.
4. Glucksberg H., Storb R., Fefer A., Buckner C.D., Neiman P.E., Clift R.A., Lerner K.G. Thomas E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18, 295 304.
5. Hansen J.A., Petersdorf E., Martin P.J. Anasetti C. (1997) Hematopoietic stem cell transplants from unrelated donors. Immunological Reviews 157, 141 151.
6. Healey G. Schwarer A.P. (2002) The helper T lymphocyte precursor frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantation. Bone Marrow Transplantation 30, 341 346.
7. Kaminski E., Hows J., Man S., Brookes P., MacKinnon S., Hughes T., Avakian O., Goldman J.M. Batchelor J.R. (1989) Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48, 608 613.
8. Kaminski E., Hows J., Goldman J. Batchelor R. (1991) Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors. Cellular Immunology 137, 88 95.
9. Keever-Taylor C.A., Passweg J., Kawanishi Y., Casper J., Flomenberg N. Baxter-Lowe L.A. (1997) Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Bone Marrow Transplantation 19, 1001 1009.
10. Kircher B., Niederwieser D., Gächter A., Lätzer K., Eibl G., Gastl G. Nachbaur D. (2004) No predictive value of cytotoxic or helper precursor T cell frequencies for outcome when analyzed from the graft after stem cell transplantation. Annals of Hematology 83, 566 572.
11. Kwok J.S.Y., Leung A.Y.H., Lie A.K.W., Lee T.L., Lau Y.L., Chu P., Jones B., Hawkins B. Liang R. (2004) Antirecipient helper and cytotoxic T-cell frequencies in bone marrow transplantation. Bone Marrow Transplantation 34, 207 213.
12. Lachance S., Le Gouvello S., Roudot F., Kuentz M., Bernaudin F., Beaujean F., Bierling P., Cordonnier C., Farcet J.-P. Vernant J.-P. (1997) Predictive value of host-specific donor helper T-cell precursor frequency of acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies. Transplantation 64, 1147 1152.
13. Montagna D., Maccario R., Comoli P., Prete L., Zecca M., Giraldi E., Daielli C., Moretta A., De Stefano P. Locatelli F. (1996) Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors. Journal of Clinical Immunology 16, 107 114.
14. Oudshoorn M., Doxiadis I.I.N., van den Berg-Loonen P.M., Voorter C.E.M., Verduyn W. Claas F.H.J. (2002) Functional versus structural matching: Can the CTLp test be replaced by HLA allele typing? Human Immunology 63, 176 184.
15. Pei J., Martin P.J., Longton G., Masewicz S., Mickelson E., Petersdorf E., Anasetti C. Hansen J. (1997) Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. Biology of Blood and Marrow Transplantation 3, 142 149.
16. Petersdorf E.W., Anasetti C., Martin P.J., Gooley T., Radich J., Malkki M., Woolfrey A., Smith A., Mickelson E. Hansen J.A. (2004) Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 104, 2976 2980.
17. Potolicchio I., Brookes P.A., Madrigal A., Lechler R.I. Sorrentino R. (1996) HLA-DPB1 mismatch at position 69 is associated with high helper T lymphocyte precursor frequencies in unrelated bone marrow transplant pairs. Transplantation 62, 1347 1352.
18. Russel C.A., Heilmann C., Madsen H.O. Vindeløv L.L. (2001) The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation. Bone Marrow Transplantation 27, 949 958.
19. Schwarer A.P., Jiang Y.Z., Brookes P.A., Barrett J.A., Batchelor R.J., Goldman J.M. Lechler R.I. (1993) Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. The Lancet 341, 203 205.
20. Schwarer A.P., Jiang Y.Z., Deacock S., Brookes P.A., Barrett J.A., Goldman J.M., Batchelor J.R. Lechler R.I. (1994) Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation. Transplantation 58, 1198 1203.
21. Scott I., O′Shea J., Bunce M., Tiercy J.M., Argüello R.J., Firman H., Goldman J., Prentice H.G., Little A.M. Madrigal J.A. (1998) Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. Blood 92, 4864 4871.
22. Shulman H.M., Sullivan K.M., Weiden P.L., McDonald G.B., Striker G.E., Sale G.E., Hackman R., Tsoi M.S., Storb R. Thomas E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine 69, 204 217.
23. Speiser D.E., Löliger C.-C., Siren M.-K. Jeannet M. (1996) Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT. British Journal of Haematology 93, 935 939.
24. Spencer A., Brookes P.A., Kaminski E., Hows J.M., Szydlo R.M., van Rhee F., Goldman J.M. Batchelor J.R. (1995) Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection. Transplantation 59, 1302 1308.
25. Storb R., Deeg H.J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C.D., Clift R., Doney K., Farewell V., Hansen J., Hill R., Lum L., Martin P., McGuffin R., Sanders J., Stewart P., Sullivan K., Witherspoon R., Yee G., Thomas E.D. (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New England Journal of Medicine 314, 729 735.
26. Taswell C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies: I. Data analysis. Journal of Immunology 126, 1614 1619.
27. Van der Meer A., Joosten I., Schattenberg A.V., De Witte T.J.M. Allebes W.A. (2000) Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation. British Journal of Haematology 111, 685 694.